229 related articles for article (PubMed ID: 32592358)
1. Glutathione S-transferase Polymorphisms in Head and Neck Squamous Cell Carcinoma Treated with Chemotherapy and/or Radiotherapy.
Maniglia MP; Russo A; Biselli-Chicote PM; Oliveira-Cucolo JG; Rodrigues-Fleming GH; -Maniglia JV; Pavarino ÉC; Goloni-Bertollo EM
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1637-1644. PubMed ID: 32592358
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma.
Essers PBM; van der Heijden M; Vossen D; de Roest RH; Leemans CR; Brakenhoff RH; van den Brekel MWM; Bartelink H; Verheij M; Vens C
Int J Cancer; 2020 Sep; 147(6):1732-1739. PubMed ID: 32167160
[TBL] [Abstract][Full Text] [Related]
3. GSTM1, GSTT1 and GSTP1 Ile105Val polymorphisms in outcomes of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation.
Pincinato EC; Costa EFD; Lopes-Aguiar L; Nogueira GAS; Lima TRP; Visacri MB; Costa APL; Lourenço GJ; Calonga L; Mariano FV; Altemani AMAM; Coutinho-Camillo C; Chone CT; Ramos CD; Altemani JMC; Moriel P; Lima CSP
Sci Rep; 2019 Jun; 9(1):9312. PubMed ID: 31249357
[TBL] [Abstract][Full Text] [Related]
4. Deletion and Single Nucleotide Polymorphisms in Common Glutathione-S Transferases Contribute to Colorectal Cancer Development.
Stojkovic Lalosevic ML; Coric VM; Pekmezovic TD; Simic TP; Pljesa Ercegovac MS; Pavlovic Markovic AR; Krivokapic ZV
Pathol Oncol Res; 2019 Oct; 25(4):1579-1587. PubMed ID: 30694518
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism in cytochrome P450 2A6 and glutathione S-transferase P1 modifies head and neck cancer risk and treatment outcome.
Ruwali M; Pant MC; Shah PP; Mishra BN; Parmar D
Mutat Res; 2009 Oct; 669(1-2):36-41. PubMed ID: 19406142
[TBL] [Abstract][Full Text] [Related]
6. Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.
Han B; Guo Z; Ma Y; Kang S; Wang Y; Wei Q; Wu X
Int J Clin Exp Pathol; 2015; 8(4):4113-9. PubMed ID: 26097600
[TBL] [Abstract][Full Text] [Related]
7. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
[TBL] [Abstract][Full Text] [Related]
8. Tobacco carcinogen-metabolizing genes CYP1A1, GSTM1, and GSTT1 polymorphisms and their interaction with tobacco exposure influence the risk of head and neck cancer in Northeast Indian population.
Choudhury JH; Singh SA; Kundu S; Choudhury B; Talukdar FR; Srivasta S; Laskar RS; Dhar B; Das R; Laskar S; Kumar M; Kapfo W; Mondal R; Ghosh SK
Tumour Biol; 2015 Aug; 36(8):5773-83. PubMed ID: 25724184
[TBL] [Abstract][Full Text] [Related]
9. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.
Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR
Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959
[TBL] [Abstract][Full Text] [Related]
10. Glutathione-associated enzymes in head and neck squamous cell carcinoma and response to cisplatin-based neoadjuvant chemotherapy.
Cabelguenne A; Loriot MA; Stucker I; Blons H; Koum-Besson E; Brasnu D; Beaune P; Laccourreye O; Laurent-Puig P; De Waziers I
Int J Cancer; 2001 Sep; 93(5):725-30. PubMed ID: 11477586
[TBL] [Abstract][Full Text] [Related]
11. Genetic Polymorphisms of Xenobiotic Metabolizing Genes (GSTM1, GSTT1, GSTP1), Gene-Gene Interaction with Association to Lung Cancer Risk in North India; A Case Control Study.
Ritambhara ; Tiwari S; Vijayaraghavalu S; Kumar M
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2707-2714. PubMed ID: 31554367
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
[TBL] [Abstract][Full Text] [Related]
13. Role of induction chemotherapy for N3 head and neck squamous cell carcinoma.
Nishikawa D; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Nakashima T; Hasegawa Y
Auris Nasus Larynx; 2015 Apr; 42(2):150-5. PubMed ID: 25498333
[TBL] [Abstract][Full Text] [Related]
14. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and tolerance of sequential chemoradiotherapy in squamous cell carcinoma of the head and neck.
Loo SW; Geropantas K; Tasigiannopoulos Z; Martin C; Roques TW
Eur J Cancer Care (Engl); 2013 Jan; 22(1):32-40. PubMed ID: 22519981
[TBL] [Abstract][Full Text] [Related]
16. Accelerated Radiotherapy with Concurrent Chemotherapy in Locally Advanced Head and Neck Cancers: Evaluation of Response and Compliance.
Mashhour K; Atef H; Selim A; A Moez M; Zawam H; Abo-Madyan Y
Asian Pac J Cancer Prev; 2020 May; 21(5):1399-1407. PubMed ID: 32458648
[TBL] [Abstract][Full Text] [Related]
17. Concurrent chemoradiotherapy for head and neck cancers in older patients: Outcomes and their determinants.
Srinivasalu VK; Subramaniam N; Balasubramanian D; Kumar N; Philip A; Susan A; Pushpaja KU; Nair AR; Thankappan K; Jose W; Iyer S; Keechilat P
Indian J Cancer; 2019; 56(3):261-266. PubMed ID: 31389391
[TBL] [Abstract][Full Text] [Related]
18. Association of GSTP1 and ERCC1 polymorphisms with toxicity in locally advanced head and neck cancer platinum-based chemoradiotherapy treatment.
Duran G; Aguín S; Cruz R; Barros F; Giráldez JM; Bernárdez B; López-López R; Carracedo Á; Lamas MJ
Head Neck; 2019 Aug; 41(8):2704-2715. PubMed ID: 30973677
[TBL] [Abstract][Full Text] [Related]
19. A Phase II Study of Genexol-PM and Cisplatin as Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma.
Keam B; Lee KW; Lee SH; Kim JS; Kim JH; Wu HG; Eom KY; Kim S; Ahn SH; Chung EJ; Kwon SK; Jeong WJ; Jung YH; Kim JW; Heo DS
Oncologist; 2019 Jun; 24(6):751-e231. PubMed ID: 30796155
[TBL] [Abstract][Full Text] [Related]
20. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
